PEG-FUSION Trademark

Trademark Overview


On Monday, April 18, 2022, a trademark application was filed for PEG-FUSION with the United States Patent and Trademark Office. The USPTO has given the PEG-FUSION trademark a serial number of 97368406. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 25, 2023. This trademark is owned by Neuraptive Therapeutics, Inc.. The PEG-FUSION trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; surgical implants comprised of biological material derived from human or animal tissue, used to protect or repair tissue of the peripheral or central nervous system

Drug delivery system for delivering pharmaceutical preparations for use on the peripheral and central nervous system; surgical implants comprised of biological material derived from human or animal tissue, used to protect or repair tissue of the peripheral or central nervous system
peg-fusion

General Information


Serial Number97368406
Word MarkPEG-FUSION
Filing DateMonday, April 18, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; surgical implants comprised of biological material derived from human or animal tissue, used to protect or repair tissue of the peripheral or central nervous system
Pseudo MarkPOLYETHYLENE GLYCOL FUSION
Goods and ServicesDrug delivery system for delivering pharmaceutical preparations for use on the peripheral and central nervous system; surgical implants comprised of biological material derived from human or animal tissue, used to protect or repair tissue of the peripheral or central nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 25, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuraptive Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027

Trademark Events


Event DateEvent Description
Thursday, April 21, 2022NEW APPLICATION ENTERED
Monday, April 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 3, 2023ASSIGNED TO EXAMINER
Wednesday, February 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 8, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 8, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, September 25, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, September 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND